Biochem Biophys Res Commun. 2025 Nov 16. pii: S0006-291X(25)01687-0. [Epub ahead of print]792 152971
Codon usage bias (CUB) and ribosome heterogeneity represent two fundamental yet traditionally separate dimensions of translational regulation. CUB, defined as the preferential use of synonymous codons, influences translation efficiency, fidelity, mRNA stability, and protein folding. Ribosome heterogeneity, arising from variability in ribosomal RNA modifications, ribosomal protein composition, and tissue-specific paralogs, generates specialized ribosomes with selective mRNA translation capacity. Emerging evidence reveals that these two regulatory axes are functionally interconnected: specialized ribosomes preferentially translate transcripts enriched in distinct codon usage patterns, regulating protein synthesis during development, stress adaptation, and disease progression. This interplay reshapes the classical view of translation by integrating codon context with ribosome specialization, forming a "ribosome code" that governs proteome composition. Disruption of this axis contributes to diverse diseases, including cancer, ribosomopathies, and neurodevelopmental disorders, where codon-specific translational reprogramming drives pathogenic protein expression. Advances in ribosome profiling, cryo-EM, and integrative computational modeling have illuminated these dynamics at unprecedented resolution, offering new opportunities for targeted therapeutic interventions. This review synthesizes current knowledge on codon-ribosome interactions, explores their mechanistic basis and functional implications, and highlights future research directions toward decoding this emerging layer of translational control.
Keywords: Codon usage bias; RNA modification; Ribosome heterogeneity; Specialized ribosomes; Translational regulation